Verition Fund Management LLC - NEVRO CORP ownership

NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 19 filers reported holding NEVRO CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of NEVRO CORP
ValueSharesWeighting
Q1 2022$4,133,000
-42.7%
3,823,000
-41.1%
0.05%
-3.8%
Q4 2021$7,219,000
-17.6%
6,486,0000.0%0.05%
-31.6%
Q3 2021$8,760,000
-31.5%
6,486,000
-12.2%
0.08%
-34.5%
Q2 2021$12,796,000
+10.9%
7,386,000
-1.3%
0.12%
-10.8%
Q1 2021$11,543,000
-2.4%
7,486,000
+15.4%
0.13%
+25.0%
Q4 2020$11,825,000
+96.9%
6,486,000
+67.4%
0.10%
-13.3%
Q3 2020$6,006,000
+72.8%
3,874,000
+52.3%
0.12%
+5.3%
Q2 2020$3,476,0002,544,0000.11%
Other shareholders
NEVRO CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Perceptive Advisors 9,000,000$165,420,0001.78%
DeepCurrents Investment Group LLC 21,930,000$39,845,0001.05%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 12,000,000$21,915,0000.43%
Polar Asset Management Partners Inc. 17,500,000$31,763,0000.34%
ZAZOVE ASSOCIATES LLC 1,320,000$2,427,0000.30%
WOLVERINE ASSET MANAGEMENT LLC 16,000,000$29,227,0000.22%
PFM Health Sciences, LP 2,000,000$3,666,0000.13%
Context Capital Management, LLC 500,000$912,0000.12%
Verition Fund Management LLC 6,486,000$11,825,0000.10%
LINDEN ADVISORS LP 3,500,000$6,401,0000.05%
View complete list of NEVRO CORP shareholders